Matthew J. Greenhawt insider trades
Open-market stock purchases and sales by Matthew J. Greenhawt, Chief Medical Officer at Aquestive Therapeutics, Inc, from SEC Form 4 filings since Mar 9, 2026.
Companies traded
- AQST Aquestive Therapeutics, Inc: other filings, last Mar 9, 2026
Get free alerts when Matthew J. Greenhawt files a new trade →